Moleculin exercises warrants for USD8.3m gross proceeds
Eupraxia Pharmaceuticals prices USD55m public offering
Lario Therapeutics awarded USD2.4m in grants for neuronal calcium channel research
EMA validates Enhertu application for post-neoadjuvant HER2-positive early breast cancer
Merck reports positive Phase 3 data for Enflonsia in high-risk children across two RSV seasons
AVEO Oncology completes first interim analysis in global Phase 3 FIERCE-HN study
Cedar Health Research opens new embedded research site within Texas Native Health
Hansa's imlifidase Biologics License Application accepted by FDA
Novartis reports positive Phase III results for remibrutinib in chronic inducible urticaria
Merck and Mayo Clinic launch AI-driven drug discovery collaboration